CAMP and neoplasm: Nevertheless, overexpression of LL-37 has also been linked to increased tumor growth, enhanced invasiveness and bad prognosis in malignant melanomas and ovarian, lung, prostate and breast cancers, by stimulating the growth receptors of the EGFR and ERB-family (187).